Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-27 pm EDT			Pre-market 07:17:17 am
479.00 ^USD	+0.34%		481.25	+0.47%

Jul. 21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
Jul. 20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	121,573	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	5.69%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	107,830	102,961	97,932
Change	-	31.13%	47.8%	4.23%	11.09%	-0.54%	-4.51%	-4.88%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	27.3x	24.1x	20x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.49x	4.55x	3.82x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.8x	1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.32x	8.47x	7.56x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.27x	7.18x	6.09x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.6x	15.5x	12.8x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19.5x	16.3x	13.2x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	21.8x	21.2x	19.1x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.59%	4.73%	5.24%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.54	19.89	24.01
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,046	14,347	16,084
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,789	6,650	7,648
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,525	6,331	7,406
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,518	5,136	6,175
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-13,743	-18,611	-23,641
Reference price ²	219.60	288.78	406.89	402.70	453.36	479.00	479.00	479.00
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.31x	8.27x	18.63x	-.--%	122B
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	17.90x	6.76x	17.14x	2.14%	378.49B
Weighted average by Cap.	24.84x	7.97x	18.76x	1.89%